US$ 27.59
bpc 157 for carpal tunnel syndrome BPC-157 can be taken orally or subcutaneously, and most people the BPC-157 Injectable Peptide for Healing
Description
Due to its structural adjustment, IGF-1 LR3 has a much longer half-life and results may persist in the bloodstream for up to 120 times longer

It is indicated for conditions such as pyridoxine deficiency from poor diet or malabsorption, anemia due to low B, and certain cases of neonatal seizures that respond to vitamin B therapy

The bacteria eat this vitamin and produce a molecule that is similar to the structure of B12 this molecule competes with vitamin B12 receptors, resulting in decreased absorption of B12

They claim that lowering the BAC to .05% or below would save 1,800 lives a year
